CV
CVRx, Inc.
CVRX · NASDAQ
$3.04 +1.67% (+$0.05)
1M -3.49%
Market Cap $80.7M
P/E Ratio -
Div. Yield -
ROE 152.35%
Piotroski F-Score Weak
3/9Valuation
73 /100
Cheap P/B 4.04x
P/S 1.32x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 28.85%
Rev. growth 36.11%
FCF growth N/A
Profitability
20 /100
Weak Net margin 84.93%
Op. margin 79.49%
FCF margin 67.09%
Quality
8 /100
Poor ROE 152.35%
ROA 56.31%
Asset turnover 0.66x
Debt
23 /100
High Current ratio 8.04x
Int. coverage -7.62x
Debt/Equity 2.98x
Stability
53 /100
Moderate Rev. volatility 32.97%
EPS volatility 28.35%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVRX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin Hykes
Employees
223
Headquarters
Minneapolis
Upcoming events
04 NOV
Earnings
Upcoming earnings report